CUMBERLAND PHARMACEUTICALS INC Income Statement
CPIX|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
CUMBERLAND PHARMACEUTICALS INC reported $12M in revenue and $1M in net income for FY2025. Revenue has declined at a 9.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.7M | $39.6M | $42.0M | $36.0M | $34.4M | $37.4M | $34.4M | $33.0M | $900.0K | $600.0K | $800.0K | $700.0K | $51.1M | $45.9M | $43.5M |
| Cost of Revenue | $6.7M | $6.1M | $9.1M | $8.8M | $7.4M | $8.7M | $7.4M | $6.0M | $5.0M | $5.1M | $5.4M | $5.0M | $5.4M | $3.6M | $4.1M |
| SG&A Expense | $11.9M | $10.7M | $10.2M | $9.8M | $10.0M | $10.2M | $10.0M | $8.6M | $7.6M | $8.4M | $9.5M | $9.1M | $9.3M | $8.1M | $7.6M |
| R&D Expense | $5.6M | $5.8M | $6.7M | $5.7M | $6.9M | $5.8M | $6.9M | $3.2M | $3.8M | $3.4M | $5.6M | $5.1M | $5.0M | $4.3M | $5.0M |
| Operating Income | $1.3M | -$9.6M | -$5.7M | -$7.7M | -$9.3M | -$6.4M | -$9.3M | -$1.4M | $1.1M | $3.6M | -$3.8M | $8.8M | $9.8M | $6.5M | $5.8M |
| Interest Expense | $496.0K | $667.9K | $586.0K | $98.0K | $246.2K | $263.6K | $246.2K | $106.4K | $73.9K | $67.1K | $103.4K | $72.0K | $353.5K | $1.4M | $772.9K |
| Income Tax | $40.3K | $45.8K | $68.8K | $34.9K | -$79.3K | $55.9K | -$79.3K | -$330.9K | $575.8K | $1.4M | -$1.5M | $3.2M | $4.1M | $2.9M | $2.0M |
| Net Income | $1.3M | -$6.3M | -$5.6M | -$3.5M | -$3.5M | -$3.3M | -$3.5M | -$944.7K | $731.4K | $2.4M | -$2.1M | $5.8M | $5.7M | $2.5M | $3.1M |
| EPS (Basic) | -$0.46 | -$0.44 | -$0.38 | -$0.24 | -$0.23 | -$0.45 | -$0.50 | -$0.06 | $0.04 | $0.14 | -$0.11 | $0.30 | $0.28 | $0.12 | $0.22 |
| EPS (Diluted) | -$0.46 | -$0.44 | -$0.38 | -$0.24 | -$0.23 | -$0.45 | -$0.50 | -$0.06 | $0.04 | $0.14 | -$0.11 | $0.30 | $0.28 | $0.12 | $0.17 |
| Shares Outstanding | 14.0M | 14.1M | 14.4M | 14.7M | 15.0M | 15.3M | 15.5M | 16.1M | 16.1M | 16.4M | 17.1M | 18.0M | 18.9M | 21.1M | 20.3M |
| Operating Margin | 11.0% | -24.2% | -13.6% | -21.3% | -27.0% | -17.0% | -27.0% | -4.3% | 123.5% | 593.1% | -475.2% | 1259.7% | 19.3% | 14.2% | 13.3% |
| Profit Margin | 10.7% | -15.9% | -13.3% | -9.8% | -10.3% | -8.9% | -10.3% | -2.9% | 81.3% | 404.0% | -263.1% | 834.6% | 11.1% | 5.4% | 7.1% |